Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cef2a6d661df17e57ad3155c24188735 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-38 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0014 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0048 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-19 |
classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-38 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-19 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00 |
filingDate |
1994-10-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2000-09-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_22e2152d5c7bc9ba55a14e1ef87c4336 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_08434449342ff04e2043a19a694b83d3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dc18d7cf65e95e672795d850f2978d5c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3b64aa38759e291f1b1d7222fca5aac5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c27bb820efc172b914ab931087a57f54 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3865b416539b7ef447aa305ec9465eb1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_da78bdef14ed4664233ed14efe61a9ba http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3b1dff91b452a54c287e3da63a485b65 |
publicationDate |
2000-09-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
CA-2202520-C |
titleOfInvention |
Lyophilized pharmaceutical preparations capable of providing aqueous drug composition having property of reversible thermosetting gelation |
abstract |
Herein disclosed is a lyophilized pharmaceutical preparation obtained by lyophilizing an aqueous composition having property of reversible thermosetting gelation and comprising an effective amount of a drug, 0.2 to 2.1 (W/V)% of methylcellulose (the content of methoxyl group is within the range of 26 to 33%), 1.2 to 2.3 (W/V)% of citric acid and 0.5 to 13- (W/V)% of polyethylene glycol. The lyophilized pharmaceutical preparation makes it possible to stably store drugs unstable to water till they are put into practical use and, upon therapeutic use, an aqueous composition having property of reversible thermosetting gelation which can undergo gelation when locally applied can easily and immediately be reconstituted from the preparation by addition of a proper amount of a solvent for reconstitution. |
priorityDate |
1994-10-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |